Alliance for Pharmacy Compounding

Alliance for Pharmacy Compounding We're the voice for pharmacy compounding and the advocate for thousands of pharmacy compounding profe

Scurvy?! Aye, matey. Healthline reported this week that some people taking GLP-1 weight-loss medications are developing ...
03/13/2026

Scurvy?! Aye, matey. Healthline reported this week that some people taking GLP-1 weight-loss medications are developing scurvy, a disease caused by severe vitamin C deficiency. If you’re wondering how someone comes down with a condition you last heard about in conjunction with the Mayflower, here’s what seems to be happening: Because the drugs suppress appetite and can lead to drastically reduced food intake, some patients are eating far fewer fruits and vegetables (or relying on low-nutrient foods to manage nausea) and may unintentionally miss essential nutrients. Experts say the GLP-1s themselves don’t cause scurvy, but proper nutrition planning or supplements may be needed to prevent vitamin and micronutrient deficiencies while using them.
https://bit.ly/47IYmvf

Meet the Experts!APC's Scott Brunner and Tenille Davis will be speaking at Informa Connect's Compounding Pharmacy Compli...
03/12/2026

Meet the Experts!

APC's Scott Brunner and Tenille Davis will be speaking at Informa Connect's Compounding Pharmacy Compliance Conference in just 2 months. Don’t miss their sessions packed with expert insights and practical strategies for navigating compliance challenges in compounding pharmacy — join them on June 9-10, 2026 in Philadelphia.

And if you're an APC member, you get 15% off registration. Contact info@a4pc.org for your special code.

Mark your calendar and register today.
https://bit.ly/4rrhtBe

At a time when policy debates, drug shortages, and market shifts continue to redefine healthcare delivery, our new Snaps...
03/11/2026

At a time when policy debates, drug shortages, and market shifts continue to redefine healthcare delivery, our new Snapshot of Pharmacy Compounding in America provides something essential: clear, industry-grounded insight from the compounding pharmacists and pharmacies doing the work every day.

For example: Did you know the median 503A compounding pharmacy dispenses approximately 350 compounded prescriptions per week and collaborates with roughly 150 prescribers?

While compounded prescriptions account for an estimated 1 to 3 percent of all U.S. prescriptions, that percentage represents substantial numbers of patients whose medical needs cannot be met by commercially available products. Scale matters. So does specialization.

Check out the Snapshot to learn more.

https://bit.ly/4rvcQWB

🚨 Thinking about becoming an APC Fellow? Now’s the time to act.The APC Fellows Program is the highest distinction APC aw...
03/11/2026

🚨 Thinking about becoming an APC Fellow? Now’s the time to act.

The APC Fellows Program is the highest distinction APC awards, recognizing pharmacists and technicians who demonstrate exceptional professionalism and commitment to pharmacy compounding.

The application takes time to complete — and the deadline for 2026 induction is March 31. Don’t wait until the last minute.

👉 Review the requirements and start your application today.
https://bit.ly/3Pfc5Ue

🚨 New episode drop! In the latest episode of Essential: The Pharmacy Compounding Podcast, Scott Brunner unpacks how some...
03/10/2026

🚨 New episode drop!

In the latest episode of Essential: The Pharmacy Compounding Podcast, Scott Brunner unpacks how some drugmakers are selling state lawmakers a fantasy about GLP-1 drugs and compounding — and why those narratives could have real consequences for pharmacies and patients.
A little myth-busting, a little policy reality check.

👉 Listen now before someone else writes the story for you.

🎧 Podbean: https://bit.ly/4bdonnp
🎧 Spotify: https://bit.ly/3NixkE1
🎧 Youtube: https://bit.ly/4blJUKU
🎧 Apple: https://apple.co/46Tej1F

The Oregon Board of Pharmacy is seeking public feedback on potential drug compounding rules and has opened a short surve...
03/10/2026

The Oregon Board of Pharmacy is seeking public feedback on potential drug compounding rules and has opened a short survey to gather input from pharmacists and stakeholders.
These rules are not yet in formal rulemaking, which means this is an early opportunity to help shape the direction before language is finalized.

If you practice in Oregon or serve any Oregon patients, it’s worth taking a few minutes to review the proposed concepts and submit comments.

🗓 Deadline: March 15, 2026
🔗 Survey: https://bit.ly/4rmSpes

Don't misss these latest, greatest hits!APC has been busy lately. Our new Snapshot of Pharmacy Compounding in America is...
03/09/2026

Don't misss these latest, greatest hits!

APC has been busy lately. Our new Snapshot of Pharmacy Compounding in America is out with fresh, shareable data about the profession.

🔗 https://bit.ly/4llbwEy

We’ve also released new best-practices guidance (including vendor validation and IV therapy compounding), and our state threat response hub is tracking anti-compounding legislation across the country.

🔗 https://bit.ly/4uau6Dc
🔗 https://bit.ly/4bkueYj

Plus, there’s a quick way to help strengthen the profession: sign up to contribute dispensing data to APC’s research project with Rollins School of Public Health at Emory University.

🔗 https://bit.ly/4ul3yzk

New resources, real advocacy, and a chance to shape the data behind compounding’s future — worth a quick catch-up.

Join us this Thursday, March 12, if you’ve ever looked at a Certificate of Analysis and wondered how it actually affects...
03/09/2026

Join us this Thursday, March 12, if you’ve ever looked at a Certificate of Analysis and wondered how it actually affects what you’re compounding. This session will clear things up.

Join Vanessa Pinheiro and Matthew Johnson for a practical walkthrough of how to interpret CoAs and apply the numbers correctly in the lab. You’ll learn how to work with assay values, moisture content, and salt-to-base conversions, perform accurate dilution calculations, and avoid the kinds of mistakes that can throw off potency or concentration.

They’ll also break down antibiotic monographs and potency expressions so you know exactly what you’re working with before you start compounding.

Bottom line: if you want greater confidence in the math and decisions behind every formulation, this is a session you won’t want to miss.

https://bit.ly/4szWhd1

Please join us in welcoming José Triana as APC's new Marketing and Creative Director! José brings valuable experience in...
03/09/2026

Please join us in welcoming José Triana as APC's new Marketing and Creative Director!

José brings valuable experience in agency and association settings and will play an important role in supporting APC's marketing efforts. His background in writing and design will help strengthen our work as we continue to advocate for pharmacies and patients alike.

We’re excited to have him on the team — welcome, José!

What you need to know about med spa regs (or the absence thereof). John Hertig’s tutorial on med-spa regulation in NABP ...
03/06/2026

What you need to know about med spa regs (or the absence thereof). John Hertig’s tutorial on med-spa regulation in NABP Innovations magazine, “Injecting Clarity: The State of Medical Spa Regulation in the US,” is a must-read.

🔗https://bit.ly/4b5OyfJ

Trying to clear some confusion in Virginia. We recently submitted a letter to the Virginia Board of Pharmacy seeking clarification on its enforcement approach to compounded GLP-1 medications. Specifically, we’re concerned that the BoP’s actions appear inconsistent with both FDA guidance and Virginia law, particularly in cases where prescriptions document a patient-specific clinical difference. Our ask: Would the board be kind enough to clarify how it interprets key terms and standards so that pharmacies can be compliant and patients can still get the meds they need?

🔗https://bit.ly/4bbBcij

⏳ Two weeks.In just 14 days, compounding pharmacy owners and managers from across the country will gather in Austin, TX ...
03/05/2026

⏳ Two weeks.

In just 14 days, compounding pharmacy owners and managers from across the country will gather in Austin, TX for APC’s 2026 Owner Summit.

Owner Summit isn't meeting just for the sake of meeting. It’s strategy. It’s resilience. It’s branding, AI, pricing psychology, risk management, and the real-world decisions that could determine whether your pharmacy is stronger five years from now than it is today.

If you’ve been meaning to register, this is your moment.
https://bit.ly/40i5gng

Two weeks. We’ll see you in Austin.

🚨 New episode drop! Peddling a Fantasy: How Drugmakers Are Misleading State LawmakersIn the latest episode of Essential:...
03/04/2026

🚨 New episode drop! Peddling a Fantasy: How Drugmakers Are Misleading State Lawmakers

In the latest episode of Essential: The Pharmacy Compounding Podcast, Andrew Kantor and APC's CEO Scott Brunner break down how some drug manufacturers are pushing misleading narratives at the state level — including efforts to restrict compounding and confusion around GLP-1 drugs — and why these tactics matter for licensed compounding pharmacies and patients who need access to compounded medications.

Tune in to hear the facts, get APC’s perspective, and understand what’s at stake for your practice and patient access to personalized therapies.

🎧 Podbean: https://bit.ly/4rbVvC3
🎧 Spotify: https://bit.ly/4cmwmAW
🎧 Youtube: https://bit.ly/4liUWoH
🎧 Apple: https://apple.co/4785qkU

Address

100 Daingerfield Road, Ste 100
Alexandria, VA
22314

Telephone

+12819338400

Website

Alerts

Be the first to know and let us send you an email when Alliance for Pharmacy Compounding posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram